MarketScreener Editorial Features Lightlake Therapeutics OTC Bulletin Board
Equities
US53224T1051
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2023 | Indivior completes acquisition of Opiant Pharmaceuticals | AN |
2023 | Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals | MT |
MarketScreener Editorial Features
![]() | MarketScreener's World Press Review : November 14, 2022 | November 14, 2022 at 09:53 pm IST |
- Stock Market
- Equities
- OPNT Stock
- Stock
- News Lightlake Therapeutics
- MarketScreener Editorial Features